Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA

Inclusion Criteria: * Post-menopausal women with subjective symptomatology of vulvovaginal atrophy * Signed written informed consent before participation in the trial Exclusion Criteria: * Known hypersensitivity against any of the ingredients of the investigational product * Systemic hormonal replacement therapy, or phytohormonal therapy or use of SERMs within 3 months before and / or during the conduct of the trial * Local hormonal therapy (vagina/vulva) within 3 months before the trial * If in the opinion of the investigator the patient should not participate in the study for any reason